Please use this identifier to cite or link to this item: 10.1002/ccr3.2182
Title: Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
Authors: Brokāne, Linda
Jaunalksne, Inta
Tilgase, Andra
Olmane, Evija
Petroška, Donatas
Rasa, Agnija
Alberts, Pēteris
Keywords: combination treatment;metastatic melanoma;nivolumab;oncolytic virus;Rigvir;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;General Medicine
Issue Date: Jun-2019
Citation: Brokāne , L , Jaunalksne , I , Tilgase , A , Olmane , E , Petroška , D , Rasa , A & Alberts , P 2019 , ' Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient ' , Clinical Case Reports , vol. 7 , no. 6 , pp. 1191-1196 . https://doi.org/10.1002/ccr3.2182
Abstract: A 35-year-old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.
Description: Publisher Copyright: © 2019 Rigvir. Clinical Case Reports Published by John Wiley & Sons Ltd.
DOI: 10.1002/ccr3.2182
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.